Kinomica

Kinomica is a UK precision medicine company developing phosphoproteomics technology for drug discovery and companion diagnostics.

Its platform combines LC-MS/MS mass spectrometry with proprietary bioinformatics to measure kinase activity directly from patient samples, enabling drug target identification, monitoring of kinase inhibitor efficacy and resistance, and patient stratification for clinical trials.

Initially focused on oncology, the platform has applications across disease areas where cell signalling dysregulation is relevant. Customers include major pharmaceutical companies.